COEP Financial Statements

Balance sheet, income statement, cash flow, and dividends for Coeptis Therapeutics Holdings Inc (COEP).


$26.74M Market Cap.

As of 03/27/2024 5:00 PM ET (MRY) • Disclaimer

COEP Market Cap. (MRY)


COEP Shares Outstanding (MRY)


COEP Assets (MRY)


Total Assets

$8.07M

Total Liabilities

$3.76M

Total Investments

$3.50M

COEP Income (MRY)


Revenue

$0

Net Income

-$21.27M

Operating Expense

$21.49M

COEP Cash Flow (MRY)


CF Operations

-$7.24M

CF Investing

$0

CF Financing

$4.92M

COEP Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

-

-

-

-

COEP Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$8,071,089 (1.96%)

$7,915,689 (17.00%)

$6,765,576 (2151.56%)

$300,484 (75.16%)

Assets Current

$5,249,713 (33.18%)

$3,941,733 (80.85%)

$2,179,558 (869.77%)

$224,751 (44405.15%)

Assets Non-Current

$2,821,376 (-29.00%)

$3,973,956 (-13.35%)

$4,586,018 (5955.51%)

$75,733 (-55.72%)

Goodwill & Intangible Assets

$0 (0%)

$3,554,167 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$4,313,964 (-10.19%)

$4,803,329 (104.34%)

$2,350,634 (145.70%)

-$5,143,343 (-32874.76%)

Property Plant & Equipment Net

$108,877 (52.37%)

$71,456 (124.34%)

$31,851 (-56.80%)

$73,732 (0%)

Cash & Equivalents

$1,469,134 (-61.25%)

$3,791,302 (73.95%)

$2,179,558 (973.86%)

$202,965 (40091.09%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$1,000,000 (0%)

Total Investments

$3,500,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$3,500,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$8,075 (0%)

$0 (0%)

$21,786 (0%)

Trade & Non-Trade Payables

$1,419,699 (1333.74%)

$99,021 (-26.15%)

$134,092 (-91.74%)

$1,623,840 (0%)

Accumulated Retained Earnings (Deficit)

-$87,356,260 (-32.88%)

-$65,739,723 (-138.62%)

-$27,550,126 (-95.38%)

-$14,100,846 (-151407.96%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,224,226 (-28.25%)

$1,706,341 (-58.20%)

$4,081,724 (95.50%)

$2,087,841 (1267.78%)

Debt Current

$1,013,047 (-34.29%)

$1,541,618 (-36.60%)

$2,431,724 (26.45%)

$1,923,118 (1159.87%)

Debt Non-Current

$211,179 (28.20%)

$164,723 (-90.02%)

$1,650,000 (901.68%)

$164,723 (0%)

Total Liabilities

$3,757,125 (20.72%)

$3,112,360 (-29.50%)

$4,414,942 (-18.90%)

$5,443,827 (3392.95%)

Liabilities Current

$2,988,696 (63.98%)

$1,822,637 (-34.08%)

$2,764,942 (-47.62%)

$5,279,104 (3287.25%)

Liabilities Non-Current

$768,429 (-40.42%)

$1,289,723 (-21.83%)

$1,650,000 (901.68%)

$164,723 (0%)

COEP Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$0 (0%)

$75,000 (143.82%)

$30,761 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$964,217 (0%)

Selling General & Administrative Expense

$14,822,881 (-56.63%)

$34,175,077 (142.02%)

$14,120,932 (144.47%)

$5,776,212 (258459.18%)

Research & Development Expense

$6,668,244 (31825.33%)

$20,887 (0%)

$0 (0%)

$3,543 (0%)

Operating Expenses

$21,491,125 (-37.15%)

$34,195,964 (142.17%)

$14,120,932 (144.32%)

$5,779,755 (258617.77%)

Interest Expense

$107,685 (-50.70%)

$218,412 (16.71%)

$187,133 (26.28%)

$148,192 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$21,266,537 (43.40%)

-$37,574,217 (-179.38%)

-$13,449,280 (-46.89%)

-$9,156,286 (-409760.61%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$21,266,537 (43.40%)

-$37,574,217 (-179.38%)

-$13,449,280 (-46.89%)

-$9,156,286 (-409760.61%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$21,266,537 (43.40%)

-$37,574,217 (-179.38%)

-$13,449,280 (-46.89%)

-$9,156,286 (-409760.61%)

Weighted Average Shares

$25,689,989 (79.70%)

$14,295,678 (30.98%)

$10,914,574 (-39.66%)

$18,089,441 (944.93%)

Weighted Average Shares Diluted

$25,689,989 (79.70%)

$14,295,678 (30.98%)

$10,914,574 (-39.66%)

$18,089,441 (944.93%)

Earning Before Interest & Taxes (EBIT)

-$21,158,852 (43.36%)

-$37,355,805 (-181.67%)

-$13,262,147 (-47.22%)

-$9,008,094 (-403127.13%)

Gross Profit

$0 (0%)

$0 (0%)

$75,000 (108.03%)

-$933,456 (0%)

Operating Income

-$21,491,125 (37.15%)

-$34,195,964 (-143.46%)

-$14,045,932 (-109.23%)

-$6,713,211 (-300401.84%)

COEP Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

-$1,750,000 (0%)

$0 (0%)

Net Cash Flow from Financing

$4,917,346 (-10.39%)

$5,487,555 (-33.21%)

$8,216,033 (183.41%)

$2,898,999 (126549.15%)

Net Cash Flow from Operations

-$7,239,514 (-86.79%)

-$3,875,811 (13.67%)

-$4,489,440 (-43.15%)

-$3,136,122 (-175691.59%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$2,322,168 (-244.08%)

$1,611,744 (-18.46%)

$1,976,593 (933.57%)

-$237,123 (-47055.05%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$575,000 (76.21%)

-$2,417,000 (-48.98%)

-$1,622,405 (-188.58%)

$1,831,500 (1922.17%)

Issuance (Purchase) of Equity Shares

$5,292,346 (61.77%)

$3,271,486 (-66.92%)

$9,889,335 (826.40%)

$1,067,499 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$477,503 (0%)

$0 (0%)

$1,897,585 (0%)

$0 (0%)

Depreciation Amortization & Accretion

$1,001,237 (-0.01%)

$1,001,384 (123.82%)

$447,413 (38.33%)

$323,428 (0%)

COEP Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-

100.00% (103.30%)

-3034.50%

Profit Margin

-

-

-17932.40% (39.76%)

-29765.90%

EBITDA Margin

-

-

-17086.30% (39.48%)

-28232.70%

Return on Average Equity (ROAE)

-738.80% (29.66%)

-1050.40% (-32.68%)

-791.70% (-321.70%)

357.10% (2784.96%)

Return on Average Assets (ROAA)

-300.20% (41.36%)

-511.90% (-2145.18%)

-22.80% (99.41%)

-3879.50% (-215427.78%)

Return on Sales (ROS)

-

-

-17682.90% (39.62%)

-29284.10%

Return on Invested Capital (ROIC)

-1164.70% (0.90%)

-1175.30% (-5077.53%)

-22.70% (-103.69%)

615.70% (34305.56%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.94 (-62.20%)

-0.58 (92.84%)

-8.13 (59.31%)

-19.98

Price to Sales Ratio (P/S)

-

-

1,455.28 (-75.71%)

5,992.39

Price to Book Ratio (P/B)

6.2 (-1.02%)

6.26 (-84.30%)

39.88 (308.47%)

-19.13

Debt to Equity Ratio (D/E)

0.87 (34.41%)

0.65 (-65.50%)

1.88 (277.50%)

-1.06 (-110.65%)

Earnings Per Share (EPS)

-0.83 (68.44%)

-2.63 (-113.82%)

-1.23 (-141.18%)

-0.51 (0%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0.01 (250.00%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.28 (-4.06%)

-0.27 (34.06%)

-0.41 (-137.57%)

-0.17 (-17200.00%)

Book Value Per Share (BVPS)

0.17 (-50.00%)

0.34 (56.28%)

0.21 (175.70%)

-0.28 (-3255.56%)

Tangible Assets Book Value Per Share (TABVPS)

0.31 (2.95%)

0.3 (-50.81%)

0.62 (3547.06%)

0.02 (-82.83%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (85.71%)

-7 (36.36%)

-11

Enterprise Value Over EBITDA (EV/EBITDA)

-1.31 (-50.29%)

-0.87 (88.05%)

-7.27 (35.95%)

-11.35

Asset Turnover

0 (0%)

0 (0%)

0 (-99.23%)

0.13 (0%)

Current Ratio

1.76 (-18.77%)

2.16 (174.49%)

0.79 (1732.56%)

0.04 (1333.33%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$7,239,514 (-86.79%)

-$3,875,811 (13.67%)

-$4,489,440 (-43.15%)

-$3,136,122 (-175691.59%)

Enterprise Value (EV)

$26,326,259 (-16.66%)

$31,587,499 (-66.10%)

$93,165,366 (-5.49%)

$98,574,210

Earnings Before Tax (EBT)

-$21,266,537 (43.40%)

-$37,574,217 (-179.38%)

-$13,449,280 (-46.89%)

-$9,156,286 (-409760.61%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$20,157,615 (44.55%)

-$36,354,421 (-183.69%)

-$12,814,734 (-47.56%)

-$8,684,666 (-388649.60%)

Invested Capital

$4,837,485 (965.70%)

$453,924 (-92.31%)

$5,902,800 (290.80%)

-$3,093,744 (-1943.36%)

Working Capital

$2,261,017 (6.70%)

$2,119,096 (462.00%)

-$585,384 (88.42%)

-$5,054,353 (-3153.59%)

Tangible Asset Value

$8,071,089 (85.05%)

$4,361,522 (-35.53%)

$6,765,576 (2151.56%)

$300,484 (75.16%)

Market Capitalization

$26,737,289 (-11.10%)

$30,077,300 (-67.92%)

$93,750,000 (-4.72%)

$98,397,188

Average Equity

$2,878,423 (-19.53%)

$3,576,982 (110.57%)

$1,698,744 (166.26%)

-$2,563,825 (-15351.78%)

Average Assets

$7,084,958 (-3.48%)

$7,340,632 (-87.57%)

$59,042,339 (24916.46%)

$236,014 (87.65%)

Invested Capital Average

$1,816,716 (-42.84%)

$3,178,362 (-94.55%)

$58,299,513 (4085.05%)

-$1,462,956 (-1280.60%)

Shares

34,108,036 (73.65%)

19,641,677 (109.51%)

9,375,000 (-2.91%)

9,656,250